Member Info for Sangijuelas1

I think you are being somewhat complacent.

Angle shareholders really aren't in a position to criticise progress made by Menarini.

Also why are the only reports about Angle's "breakthrough" on their website and Proactive?

Nothing at all in the industry press

Menarini have achieved a helluva lot more than Angle over the last 10 years in terms of test development and partnerships.

And they have been combining CTC with ctDNA for a number of years now.

I understand fully it's limitations.

But as per the article it is sufficient for HER2 expression.

Cellsearch has been on the market for a good few years now.

They first got FDA clearance for CTC enumeration in 2004 so a long way down the commercialisation path already.

You really haven't done any research into what you are advising others to buy, have you?

I have never posted the Cellsearch news before.

I was only aware of it this morning.

You obviously don't know what Cellsearch is.

Sad really

Quite a few Angle prisoners will be grateful to get their release!

Because they have no idea what they are buying and what their main competition announced last week.

Https://www.clinicaltrialsarena.com/news/menarini-reports-positive-results-for-ctc-phenotyping-test-in-breast-cancer/

Great new results for Cell search CTC counter!

I was nearly right about the drop to 18p. Didn't expect 17p so quickly.

New end of week PT is 14p

Nothing has changed since my analysis the other day.

Yeah but not a first line diagnostic like Grail.

More an alternative to tissue biopsy to assess metastasis etc

Parsortix is not really a cancer screening tool though is it?

Monkshood

I actually thought you were smarter than that.

Parsortix and Grail are 2 completely different propositions.

I think the paper hands all sold out

Thought it had hit bottom

Actually surprised it's down as low as this

But they need to find a 3rd party to fund commercialisation once it is developed

They said Bioview would take a year back in April last year

No I leave that to Newland!